ClinicalTrials.gg
Status unknownNCT05182333Updated Jan 10, 2022

Congenital Hand and Upper Extremity Malformations

An observational study in Congenital Limb Anomaly Nos, sponsored by Assiut University. Status unknown. Per ClinicalTrials.gov, last updated 2022-01-10.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
100
Sex
All
01

Study summary

Getting the incidence of upper limb anomalies in our department from 2000 to 2020 and classifying them using IFSSH classification and OMT classification

Read the detailed description

A retrospective look at the past 20 years illustrated the changes and developments that characterize the world of hand surgery. During these years, old techniques were developed and standardized, new surgical techniques were described, our knowledge improved and illustrated by better classification systems, and new ideas were born that would guide the future of hand surgery. Limb deformities are among the most common birth defects in infants. Over the past 150 years, many classifications of limb abnormalities based on bone morphology and anatomy have been developed.

Congenital anomalies of the hand require consistent and reproducible terminology, and it is a universal language that allows discussion of complex clinical entities, treatment indications and outcome comparisons.

Ideally, the classification of congenital anomalies of the hand will depend on the etiology, giving some indication of the location in the molecular pathway and / or the anatomical location in the developing limb bud where the error occurs and the moment when the fault occurs. The terms should be understandable to geneticists, anatomists, pathologists, and surgeons, and they should allow easy interpretation to parents and, where appropriate, children affected by these conditions. The classification of congenital anomalies of the upper extremity and the important association of these anomalies with systemic disorders and syndromes are described in this study. Depending on the classification, examples are given for each class of anomalies.

02

Conditions studied

  • Congenital Limb Anomaly Nos

Keywords

  • Congenital upper limb anomalies
03

In context

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients with congenital upper limb anomalies

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- All patients with congenital upper limb anomalies in last 20 years in Assiut university hospital.

Exclusion criteria

Exclusion Criteria:

  • Conditions that were considered to be difficult to correctly classify because of late presentation, a large span of clinical presentation, extremely rare conditions, and conditions difficult to differentiate from traumatic conditions were excluded (ie, congenital radial head dislocation, congenital tumorous conditions, Marfan syndrome)
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OtherExamination

    History taking, examination of upper limb

06

What researchers measure

Primary outcomes

  1. Incidences of anomalies

    Getting the incidences of the upper limb anomalies in upper Egypt

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • McCarroll HR. Congenital anomalies: a 25-year overview. J Hand Surg Am. 2000 Nov;25(6):1007-37. doi: 10.1053/jhsu.2000.6457. PubMed 11119659 ↗
  • Tayel SM, Fawzia MM, Al-Naqeeb NA, Gouda S, Al Awadi SA, Naguib KK. A morpho-etiological description of congenital limb anomalies. Ann Saudi Med. 2005 May-Jun;25(3):219-27. doi: 10.5144/0256-4947.2005.219. PubMed 16119523 ↗

Individual participant data

Plan to share: Undecided — Congenital Hand and Upper Extremity Malformation in Upper Egypt-during the Last Twenty Years

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05182333
Lead sponsor
Assiut University
Responsible party
Shady Magdy Makar Salieb (Principle investigator, Assiut University) — Principal investigator
First posted
Jan 10, 2022
Start date
Feb 1, 2022 (estimated)
Primary completion
Jun 1, 2022 (estimated)
Completion
Jul 1, 2022 (estimated)
Last update
Jan 10, 2022

Study contacts

Shady Salieb, MD
Contact
shadymagdy93@gmail.com
+201028700865
Mostafa El-Sonbati, Professor
Contact
mostafaelsonbati1@med.aun.edu.eg
+201003142066

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion